MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0079568
Orbit Chem Pharmaceuticals Private Limited - pharma in Cherapalli, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹94.95 Lakh
▼ 51% YoY
Net loss · FY 2024
₹1.65 Lakh
Net margin -1.7%
EBITDA · FY 2024
₹6.54 Lakh
EBITDA margin 6.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Orbit Chem Pharmaceuticals Private Limited
Data last updated:
Orbit Chem Pharmaceuticals Private Limited is a private limited company based in Cherapalli, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 04 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33309TG2019PTC135215. Its GSTIN is 36AADCO0129L1ZH (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Babu Rao Dumala and Mahesh Kumar Doomala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 183 Survey No. 186/1 186/2 3, Cherapalli, Telangana, India – 500051.
As per the financials filed for FY 2024, the company reported a revenue of ₹94.95 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹1.65 Lakh (net margin -1.7%) and EBITDA of ₹6.54 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 70% over three years.
The company is associated with 1 brand: Orbit Chem Pharmaceuticals.
Orbit Chem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0079568). For more details, the company can be reached via its website orbitchempharmaceuticals.com.
Company details
CIN U33309TG2019PTC135215
Registration Number 135215
Incorporation Date 04 September 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0079568
Recognitions & Rankings of Orbit Chem Pharmaceuticals
Contact details
Orbit Chem Pharmaceuticals Private Limited's registered office is in Cherapalli, Telangana. Its website is orbitchempharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 183 Survey No. 186/1 186/2 3, Cherapalli, Telangana, India – 500051
- IndustryPharma, API Manufacturers
To see the full contact details of Orbit Chem Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Orbit Chem Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Orbit Chem Pharmaceuticals operates one associated brand: Orbit Chem Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract research in pharmaceutical intermediates, speciality chemicals, and agro chemicals in India. | orbitchempharmaceuticals.com |
Business activity
The main business activity of Orbit Chem Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Orbit Chem Pharmaceuticals Private Limited, buy the company report.
Financials of Orbit Chem Pharmaceuticals Private Limited
FY 2025 filings availableOrbit Chem Pharmaceuticals Private Limited reported revenue of ₹94.95 Lakh (down 51% YoY) for FY 2024.
Revenue · FY 2024
₹94.95 Lakh ▼ 51%
Net loss · FY 2024
₹1.65 Lakh margin -1.7%
EBITDA · FY 2024
₹6.54 Lakh margin 6.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 51%
3 years · compounded
▲ 70%
EBITDA CAGR growth
1 year
▲ 148%
3 years · compounded
▲ 31%
Revenue fell 51% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 70%. EBITDA rose 148% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orbit Chem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Orbit Chem Pharmaceuticals Private Limited
Orbit Chem Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babu Rao Dumala | Director | 04 Sep 2019 | 7 Years 2 Months | Current |
| Mahesh Kumar Doomala | Director | 07 Jul 2022 | 4 Years 4 Months | Current |
| Naresh Kumar Dumala | Director | 10 Apr 2021 | 5 Years 6 Months | Current |
Auditor
Orbit Chem Pharmaceuticals Private Limited is audited by NANKANI & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NANKANI & ASSOCIATES | FY 2021 | 014976S |
Shareholding
The shareholding of Orbit Chem Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Orbit Chem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orbit Chem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orbit Chem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orbit Chem Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCO0129L1ZH | Telangana | Active | 25 Sep 2019 |
To see the full GST registrations and return filing status of Orbit Chem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Orbit Chem Pharmaceuticals Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Mahesh Kumar Doomala was appointed as Director on 07 Jul 2022.
AGM
Orbit Chem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Orbit Chem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Mahesh Kumar Doomala was appointed as Director.
Ceased
Rama Koteshwar Sirimalla ceased to be Director.
Appointed
Naresh Kumar Dumala was appointed as Director.
Ceased
Uma Devi Nagurla ceased to be Director.
Ceased
Venkateshwarlu Nagurla ceased to be Director.
Ceased
Ravi Guguloth ceased to be Director.
Appointed
Babu Rao Dumala was appointed as Director.
Incorporation
04 Sep 2019
Orbit Chem Pharmaceuticals Private Limited was registered on 04 Sep 2019 with Roc Hyderabad & aged 7 years 2 months as per MCA records.
Frequently asked questions
Orbit Chem Pharmaceuticals is an active private limited company based in Cherapalli, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 04 September 2019 (7+ years old) and is registered under CIN U33309TG2019PTC135215.
Orbit Chem Pharmaceuticals has 3 current directors:
- Babu Rao Dumala - Director
- Mahesh Kumar Doomala - Director
- Naresh Kumar Dumala - Director
The latest financial statements of Orbit Chem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Orbit Chem Pharmaceuticals is 36AADCO0129L1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Orbit Chem Pharmaceuticals is U33309TG2019PTC135215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orbit Chem Pharmaceuticals was incorporated on 04 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mahesh Kumar Doomala was appointed as Director on 07 Jul 2022. Rama Koteshwar Sirimalla ceased to be Director on 01 Jul 2021. Naresh Kumar Dumala was appointed as Director on 10 Apr 2021. Orbit Chem Pharmaceuticals has 7 board changes on record in total.
Yes, Orbit Chem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0079568).
Orbit Chem Pharmaceuticals can be reached through the website orbitchempharmaceuticals.com. Its registered office is in Cherapalli, Telangana, India.
The registered office of Orbit Chem Pharmaceuticals is at Plot No. 183 Survey No. 1861 1862 3, Cherapalli, Telangana, India – 500051.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages